What's new

Human medicines European public assessment report (EPAR): Lyvdelzi (previously Seladelpar Gilead), Seladelpar lysine dihydrate, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Lyvdelzi (previously Seladelpar Gilead), Seladelpar lysine dihydrate, Revision: 3, Status: Authorised

May 16, 2025 - 14:50
 0
Human medicines European public assessment report (EPAR): Lyvdelzi (previously Seladelpar Gilead), Seladelpar lysine dihydrate, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Lyvdelzi (previously Seladelpar Gilead), Seladelpar lysine dihydrate, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date ...

Next Article

Human medicines European public assessment report (EPAR): Sibnayal, potassium ci...

Related Posts

Opinions and letters of support on the qualification of novel methodologies for medicine development

Opinions and letters of support on the qualification of...

May 8, 2025  0

EMA recommendation to update the antigenic composition ...

May 16, 2025  0

Questions and answers for biological medicinal products

Questions and answers for biological medicinal products

May 8, 2025  0